Fundraising Fox

Matthew Hobson

Investor

Analyst at Catalio Capital Management, LP

Baltimore, Maryland

Writes $100K – $5M checks Β· typically $1.5M

About

Matthew Hobson is a Principal at Catalio Capital Management, where he focuses on therapeutics and diagnostics investments across the firm's venture and private credit strategies. He joined Catalio at its 2020 founding, having previously been a Postdoctoral Fellow at the Johns Hopkins School of Medicine, where he also earned a PhD in biophysics and biophysical chemistry. He holds a B.S. in chemistry and physics from Emory University.

Invests in

BiotechDigital Health

Experience

  1. Catalio Capital ManagementPrincipalcurrent2023 β€” presentNew York, United States
  2. Catalio Capital ManagementSr. Analyst2020 β€” 2023New York, New York, United States
  3. The Johns Hopkins University School of MedicinePostdoctoral Researcher2020 β€” 2021Baltimore, Maryland, United States
  4. The Johns Hopkins University School of MedicinePHD Candidate2013 β€” 2020Baltimore, Maryland
  5. Emory University Department of ChemistryUndergraduate Researcher2010 β€” 2013
  6. National Institutes of HealthContractor2010 β€” 2012NIH Clinical Center, Bethesda, MD
  7. Walter Reed Army Institute of ResearchIntern2009

Education

  1. The Johns Hopkins University School of MedicineDoctor of Philosophy - PhD, Biophysics and Biophysical Chemistry2013 β€” 2019
  2. Emory UniversityBachelor of Science (B.S.), Chemistry and Physics2009 β€” 2013
  3. The Johns Hopkins UniversityDoctor of Philosophy (PhD), Biophysics

Skills & more

Financial AnalysisValuationRegulatory AnalysisClinical Trial AnalysisProtein EngineeringStructural BiologyMarket AnalysisData AnalysisMicroscopyAssay DevelopmentMarket ResearchProtein Expression
+12 moreFluorescence MicroscopyProtein PurificationCryoEMBiophysicsComputational BiologyX-ray crystallographyVector CloningChemical SynthesisFluorescence AnisotropyProtein CrystallizationNanoparticle FunctionalizationMagnetic Tweezers

From Matthew's professional profile.

Same school

Shared employers

Investments

Board seats

Iambic TherapeuticsLassen TherapeuticsOctant TherapeuticsPink Dx

Per the firm's website.

Colleagues at Catalio Capital Management, LP